Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1972 of 5804
-
New prostate implant aims to ease bathroom struggles without pills
Symptom relief OngoingA study to evaluate the safety, performance, and effectiveness of the ProVee Urethral Expander System (Investigational Device) when used in subjects with symptomatic urinary obstruction related to benign prostatic hyperplasia (BPH).
Phase: NA • Sponsor: ProVerum Medical • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New mRNA flu shot enters first human tests
⭐️ VACCINE ⭐️ CompletedThis is a Phase I, first-in-human, randomized, modified double-blind, active-controlled, dose-escalation study to assess the safety and immunogenicity of up to 3 dose levels of mRNA NA vaccines, administered as a single IM injection in healthy adults aged 18 years and older. Two …
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 17:10 UTC
-
New drug targets Hard-to-Treat cancers with KRAS G12D mutation
Disease control Recruiting nowThis is an open-label study. This means that people in this study and clinic staff will know that people will receive ASP3082. The study aims to check how safe and well-tolerated ASP3082 is for people with advanced solid tumors that have a specific mutation called KRAS G12D. Thi…
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug targets stomach and pancreatic cancers in early trial
Disease control Recruiting nowClaudin 18.2 protein, or CLDN18.2 is a protein found on cells in the digestive system. It is also found on some tumors. Researchers are looking at ways to attack CLDN18.2 to help control tumors. ASP2138 is thought to bind to CLDN18.2 and a protein on a type of immune cell called …
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Prostate cancer treatment may harm your heart – new study investigates
Knowledge-focused OngoingThis clinical trial investigates the impact of prostate cancer treatment, specifically androgen deprivation therapy (ADT), on the heart and coronary vessels among men with localized, non-metastatic prostate cancer undergoing definitive radiation therapy and concomitant ADT. Recen…
Phase: PHASE2 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Could skipping a day of antipsychotics reduce side effects without worsening symptoms?
Disease control Recruiting nowThe study wishes to examine whether "extended" antipsychotic treatment, in this case, antipsychotic treatment every other day, is as effective as daily treatment. It is also evaluating whether there may be differences in terms of side effects. Participants will be randomly assig…
Phase: PHASE4 • Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could SAGE-718 boost brain power in Parkinson's?
Symptom relief CompletedThe primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Parkinson's disease mild cognitive impairment (PD-MCI).
Phase: PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 16:18 UTC
-
New varnish could stop cavities before they start in young children
Prevention CompletedThe purpose of the study is to determine the efficacy \& safety of Advantage Anti-Caries Varnish for primary prevention. The objectives are: 1\) To determine if Advantage Anti-Caries Varnish (test varnish) is superior to an active control varnish (5% Sodium Fluoride, no Povidone…
Phase: PHASE2 • Sponsor: Advantage Silver Dental Arrest, LLC • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Urine test after a single dose of furosemide may spot kidney danger in ICU patients
Diagnosis CompletedThe goal of this clinical trial is to learn if serum biomarkers can better predict worsening of acute kidney injury (AKI) compared to the Furosemide Stress Test (FST) in adult patients with low albumin levels (hypoalbuminemia) admitted to an intensive care unit (ICU). The main qu…
Phase: NA • Sponsor: Maithe Caroline Inacio • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Aspirin shows promise in cutting colon cancer risk
Prevention OngoingThis research study is studying a drug intervention as a possible chemoprevention strategy for colorectal cancer. The name of the study intervention involved in this study is: * Low Dose Aspirin
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Can we predict psychosis? global study seeks answers
Knowledge-focused OngoingThe Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) is a large international collaboration to develop algorithms using a set of clinical and cognitive assessments, multi-modal biomarkers, and clinical endpoints that can be used to predict the trajectories and outcome…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Blood marker may predict COVID-19 survival
Knowledge-focused CompletedRecently, a study showed that markers of neutrophil extracellular traps formation, a mechanism corresponding to neutrophil activation, were increased in patients who died of COVID 19 compared with survivors. The investigators propose to analyze the NEU-SFL parameter, obtained au…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Can talking and sorting help older adults overcome hoarding?
Symptom relief CompletedThis study will compare two behavioral interventions for hoarding disorder in older adults.
Phase: NA • Sponsor: Mississippi State University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New protocol aims to save more premature babies from severe complications
Knowledge-focused OngoingThe intervention proposed is a new organization of care, based on the EXPRIM (EXtrem PRematurity Innovative Management) protocol, involving early, standardized, and multidisciplinary management of women hospitalized for a risk of extremely preterm birth and their children. It wil…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
New probe aims to zap lung tumors through a scope
Disease control Recruiting nowThis research study to determine the effectiveness of the AveCure Flexible Microwave Ablation Probe to destroy cancerous lung nodules up to 3 c m in size. This research study involves microwave ablation (MWA)
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Talking your way to a healthier liver: study tests motivational coaching for fatty liver
Disease control CompletedThe goal of this study is to assess if motivational counselling works to reduce the weight in participants with Non Alcoholic Fatty Liver Disease (NAFLD).
Phase: NA • Sponsor: Madunil Anuk Niriella • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New heart procedure aims to tame racing heartbeat without drugs
Symptom relief OngoingInappropriate Sinus Tachycardia (IST) is a prevalent and debilitating condition in otherwise healthy younger patients, resulting in significant loss of quality of life, lacking effective treatment options or systematic clinical evidence to support a therapy. The primary objective…
Phase: NA • Sponsor: AtriCure, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Which shoulder surgery works best for seniors with arthritis? a Head-to-Head trial
Disease control OngoingOsteoarthritis (OA) is the most common form of arthritis, affecting millions of people worldwide and it is common in an aging population. Surgical shoulder replacement (arthroplasty) is typically considered when non-surgical measures, such as physiotherapy or medication, have fai…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New inhaler drug shows promise for COPD inflammation
Disease control Recruiting nowThis is a randomized, double-blind, placebo-controlled, two-period cross-over study of nebulized ensifentrine (3 mg) or placebo administered BID for two 8-week Treatment Periods. All participants with receive both ensifentrine and placebo during participation. There are 7 in-clin…
Phase: PHASE2 • Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Time-Restricted eating: a simpler way to control diabetes?
Disease control CompletedHyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delive…
Phase: NA • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC